Table 3. Changes in IQGAP Protein Expression Level in Neoplasms‡.
Tissue Comparison | IQGAP | Species | Method | Neoplasm | Expression Change | Refs |
---|---|---|---|---|---|---|
Cancer vs Normal | IQGAP1 | Human | IHC | Colorectal | + | [80] |
MS | Squamous Cell (Head and Neck) | + | [82] | |||
WB | Astrocytoma | + | [81] | |||
WB | Breast | + | [23] | |||
IQGAP2 | Human | IHC | Gastric | - | [76] | |
Mouse | IHC/WB | Liver | - | [47] | ||
Aggressive vs Less Aggressive Cancer† | IQGAP1 | Human | IHC | Gastric | + | [83]a |
Glioma | + | [88]b | ||||
Lung | + | [100]c | ||||
Ovary | + | [84]d | ||||
IHC/WB | Glioma | + | [87]e |
increased expression;
decreased expression.
Aggressive vs less aggressive cancer is defined by a decrease in long-term survivala,b,d, an increase in the likelihood of metastasisc,e.
Only published studies with primary tissue are included. Data with cultured cell lines have been omitted.
Abbreviations: IHC, immunohistochemistry; WB, western blot; MS, mass spectrometry.